WealthSpring Partners’s Amgen AMGN Stock Holding History

WealthSpring Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$290K	Sell	800 -18	-2%	-$6.16K	0.25%	56
2026 Q1	$288K	Buy	818 +1	+0.1%	+$356	0.26%	53
2025 Q4	$267K	Buy	+817	New	+$259K	0.27%	48
2023 Q3	$401K	Sell	1,494 -20	-1%	-$4.99K	0.3%	46
2023 Q2	$336K	Buy	1,514 +38	+3%	+$8.82K	0.24%	54
2023 Q1	$357K	Buy	1,476 +2	+0.1%	+$491	0.28%	54
2022 Q4	$387K	Sell	1,474 -18	-1%	-$4.83K	0.3%	54
2022 Q3	$336K	Buy	+1,492	New	+$362K	0.3%	55

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

WealthSpring Partners's AMGN Position: Q2 2026 in Review

WealthSpring Partners reduced its Amgen (AMGN) stake by 2.2% in Q2 2026, selling an estimated $6.16K and leaving 800 shares worth $290K. The position accounts for 0.25% of the portfolio, ranked #56.

WealthSpring Partners first reported a position in AMGN in Q3 2022 and has held it in 8 quarters since. The position peaked at $401K in Q3 2023. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

WealthSpring Partners held 800 shares of Amgen worth $290K as of Q2 2026.
WealthSpring Partners sold 18 Amgen shares in Q2 2026, an estimated $6.16K.
Amgen made up 0.25% of WealthSpring Partners's portfolio in Q2 2026, its #56 holding.
WealthSpring Partners first reported a position in Amgen in Q3 2022 and has held it in 8 quarters since.
WealthSpring Partners's Amgen position peaked at $401K in Q3 2023.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on WealthSpring Partners's 13F filing for Q2 2026, filed 5 Aug 2026.